The Investment Truth Detector – How’s Joel Litman’s System?

Today, a professor who’s lectured at Harvard University is unveiling one of the biggest investment breakthroughs of the 21st century…

The Investment Truth Detector.

It’s a new way to see which stocks could soon double or triple your money… using lie detection and forensic analysis of the U.S. stock market.

Type in any ticker to see which stocks are reporting false earnings – and how to see the TRUE earnings… weeks or even months before the mass public.

So far, its findings have been featured in Barron’s, CNBC, and the Harvard Business Review, and have attracted 9 of the top 10 global investment houses and more than half of the world’s top 300 money managers.

People pay up to $500,000 a year to use it, for good reason.

By cutting through false earnings, the Investment Truth Detector has pointed to extraordinary gains of 6,734% on Jazz Pharma… 4,497% on Lululemon… and dozens more.

Professor Litman has been awarded a U.S. patent for his online system, and been invited to speak at the top MBA programs and CFA societies in the world.

Along the way, he’s attracted multibillion-dollar hedge funds, government-run sovereign funds, billionaires, and top financial advisors…

But today, the Professor is offering free access to his system here.

One little company’s earnings are hundreds of percent higher than what the public believes to be true… which could make you a fortune if you act on this information right now.

See the Professor’s Truth Analysis here.

Photo of author
Mark Winkel is a U.S.-based author and entrepreneur who lives in the greater New York City area. He studied marketing at the University of Washington and started actively investing in 2017. His approach to the markets blends fundamental research with technical chart analysis, and he concentrates on both swing trades and longer-term positions. Mark's mission is to share tips and strategies at Steady Income to help everyday people make smarter money moves. Mark is all about making finance easier to understand — whether you're just starting out or have been trading for years.


You may also like these posts...

choosing between ai etfs and individual stocks

Choosing Between AI ETFs and Individual Stocks: Understanding AI, AI Investment Strategies

Explore the advantages of AI ETFs versus individual stocks with our in-depth guide. Understand AI investment strategies and make informed decisions. Whether you're focused on diverse portfolios or single stock picking, discover which approach suits your financial goals. Stay ahead in the AI investment game with expert insights tailored for today's savvy investors.
Dave Lashmet's The Triple Play Three 1,000% Obesity Drug Companies

Dave Lashmet’s The Triple Play: Three 1,000% Obesity Drug Companies

Dave Lashmet is out with a new interview about three tiny drug makers with 10x potential for his Stansberry Venture Technology newsletter.